RELIEF CARDIOVASCULAR REPORTS POSITIVE FIRST-IN-HUMAN DATA FOR DEVICE-BASED DECONGESTION THERAPY IN HEART FAILURE PATIENTS

Relief Cardiovascular, Inc., a private medical device company developing intelligent device-based therapy solutions for heart failure (HF) congestion, today announced positive 90-day results from the ...
MassDevice

Relief Cardiovascular has positive first-in-human smart heart implant data

Relief Cardiovascular has announced positive 90-day results from a study of its smart heart implant technology.
TCTMD

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study Receive the the latest news, research, and presentations from ...
TCTMD

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...